METADATE CD is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age.

Eligible patients pay as little as $0 per month* for METADATE CD - for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients
Eligible patients pay as little as $0 per month* for METADATE CD - for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients

METADATE CD is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 15 years of age.

METADATE CD® Extended-Release methylphenidate is available in 6 dosage strengths

METADATE CD Extended-Release methylphenidate available in 6 dosage strengths
METADATE CD Extended-Release methylphenidate available in 6 dosage strengths
Metadate CD (methylphenidate HCL, USP) extended release capsules

Convenience of once-daily dosing

Available in six capsule strengths

Sprinkle dose option on applesauce

Prescribing METADATE CD

Treatment Considerations

Before prescribing METADATE CD, HCPs should assess for the following:

Risk of abuse, misuse, and addiction prior to prescribing, and frequently monitor for signs of abuse, misuse, and addiction

Presence of cardiac disease

Family history and clinically evaluate patients for tics or Tourette’s syndrome

Additional treatment considerations, and dosing information can be found in the Full Prescribing Information

Abuse, misuse, and addiction. METADATE CD has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Misuse and abuse of METADATE CD, other methylphenidate containing medicines, and amphetamine containing medicines, can lead to overdose and death. The risk of overdose and death is increased with higher doses of METADATE CD or when it is used in ways that are not approved, such as snorting or injection.

Eligible patients pay as little as
$0 per month*

Download copay card
Eligible patients pay as little as $0 per month* for METADATE CD - extended-release methylphenidate

Most Important Information About METADATE CD

Abuse, misuse, and addiction. METADATE CD has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Misuse and abuse of METADATE CD, other methylphenidate containing medicines, and amphetamine containing medicines, can lead to overdose and death. The risk of overdose and death is increased with higher doses of METADATE CD or when it is used in ways that are not approved, such as snorting or injection.

  • Risks for people with serious heart disease. Sudden death has happened in people who have heart defects or other serious heart disease. Your healthcare provider should check your child carefully for heart problems before starting METADATE CD. Tell your healthcare provider if your child has any heart problems, heart disease, or heart defects. Call your healthcare provider or go to the nearest hospital emergency room right away if your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking METADATE CD.
  • Increased blood pressure and heart rate. Your healthcare provider should check your child’s blood pressure and heart rate regularly during treatment with METADATE CD.
  • Mental (Psychiatric) problems: Tell your healthcare provider about any mental problems your child has, or about a family history of suicide, bipolar illness, depression, new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real), or new manic symptoms. Call your healthcare provider right away if your child has any new or worsening mental symptoms or problems while taking METADATE CD, especially seeing or hearing things that are not real, believing things that are not real, or are suspicious.

What is METADATE CD: METADATE CD is a central nervous system (CNS) stimulant prescription medicineused for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children under 6 to 15 years of age. METADATE CD may help increase attention and decrease impulsiveness and hyperactivity in children 6 to 15 years of age with ADHD. It is not known if METADATE CD is safe and effective in children under 6 years of age.

You should avoid drinking alcohol during treatment with METADATE CD.

METADATE CD is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs. Keep METADATE CD in a safe place to protect it from theft. Never give your METADATE CD to anyone else because it may cause death or harm them. Selling or giving away METADATE CD may harm others and is against the law.

Do Not Give METADATE CD to Your Child if They are: METADATE CD should not be taken if you or your child:

  • Are allergic to methylphenidate or any of the ingredients in METADATE CD
  • Has a rare inherited problem with breaking down, absorbing, and processing of certain types of sugar in the body. METADATE CD contains a type of sugar called sucrose.
  • Are taking or have taken within the past 14 days a medicine used to treat depression called a monoamine oxidase inhibitor MAOI

Before Taking METADATE CD Tell Your Child’s Healthcare Provider About All Medical Conditions, Including if Your Child:

  • Has heart problems, heart disease, heart defects, or high blood pressure
  • Has mental problems including psychosis, mania, bipolar illness, or depression or has a family history of suicide, bipolar illness, or depression
  • Has circulation problems in fingers or toes
  • Have eye problems, including increased pressure in your eye, glaucoma, or problems with your close-up vision (farsightedness)
  • Have, or had repeated movements or sounds (tics) or Tourette’s syndrome, or have a family history of tics or Tourette’s syndrome
  • Is pregnant or plans to become pregnant. It is not known if METADATE CD will harm the unborn baby.
  • is breastfeeding or plan to breastfeed. METADATE CD passes into breast milk. Talk to your healthcare provider about the best way to feed the baby during treatment with METADATE CD.

Tell your healthcare provider about all of the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements. METADATE CD and some medicines may interact with each other and cause serious side effects. Sometimes the doses of other medicines will need to be adjusted during treatment with METADATE CD. Your healthcare provider will decide whether METADATE CD can be taken with other medicines. Especially tell your healthcare provider if your child takes anti-depression medicines including MAOIs.

Your child should not start any new medicine during treatment with METADATE CD without talking to your healthcare provider first.

The most common side effects of METADATE CD include anorexia and trouble sleeping.  METADATE CD can cause serious side effects, including:

  • Painful or prolonged erections (priapism). If your child develops priapism, get medical help right away.
  • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon): fingers and toes may feel numb, cool, painful and/or change from pale to blue or red. Tell your healthcare provider if your child has numbness, pain, skin color change, sensitivity to temperature in their fingers or toes, or any signs of unexplained wounds appearing on fingers or toes during treatment with METADATE CD.
  • Slowing of growth (height and weight in children). Children should have their height and weight checked often during treatment with METADATE CD. METADATE CD treatment may be stopped if your child is not gaining weight or height.
  • Eye problems (increased pressure in the eye and glaucoma). Call your healthcare provider right away if your child develops changes in their vision or eye pain, swelling, or redness.
  • New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare provider if your child gets any new or worsening tics or worsening Tourette’s syndrome during treatment with METADATE CD.
  • The most common adverse reactions for METADATE CD are headache, abdominal pain (stomachache), anorexia, and insomnia. These are not all the possible side effects of METADATE CD. See full prescribing information for Postmarketing Experiences.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please click here for Full Medication Guide.